The microdevice consists in two side chambers utilized to load the conditioned medium (i.e., the anti-PD-1 antibodies) and a central compartment employed to load human tumor spheroids or tumor cells from mouse colon cancer lesions which develop organoids several days after loading (Aref et al., 2018). Here, PDCD1 is linked to neoplasm.